Keywords
Last Name

David Shrayer, MD, PhD

TitleResearch Assistant Professor
InstitutionBoston University School of Medicine
DepartmentSurgery
DivisionGeneral Surgery
Address
 Publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Falanga V, Iwamoto S, Chartier M, Yufit T, Butmarc J, Kouttab N, Shrayer D, Carson P. Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng. 2007 Jun; 13(6):1299-312. PMID: 17518741.
    View in: PubMed
  2. Eberting CL, Shrayer DP, Butmarc J, Falanga V. Histologic progression of B16 F10 metastatic melanoma in C57BL/6 mice over a six week time period: distant metastases before local growth. J Dermatol. 2004 Apr; 31(4):299-304. PMID: 15187325.
    View in: PubMed
  3. Shrayer DP, Bogaars H, Cole B, Wolf SF, Wanebo HJ. Capacity of murine IL-12 to inhibit the development of primary melanoma tumors and to prevent lung metastases in the melanoma-challenged mice. J Exp Ther Oncol. 2002 Mar-Apr; 2(2):93-9. PMID: 12415625.
    View in: PubMed
  4. Shrayer DP, Cole B, Hearing VJ, Wolf SF, Wanebo HJ. Immunotherapy of mice with an irradiated melanoma vaccine coupled with interleukin-12. Clin Exp Metastasis. 1999 Feb; 17(1):63-70. PMID: 10390149.
    View in: PubMed
  5. Shrayer DP, Bogaars H, Wolf SF, Hearing VJ, Wanebo HJ. A new mouse model of experimental melanoma for vaccine and lymphokine therapy. Int J Oncol. 1998 Aug; 13(2):361-74. PMID: 9664134.
    View in: PubMed
  6. Hofer SO, Shrayer D, Reichner JS, Hoekstra HJ, Wanebo HJ. Wound-induced tumor progression: a probable role in recurrence after tumor resection. Arch Surg. 1998 Apr; 133(4):383-9. PMID: 9565118.
    View in: PubMed
  7. Shrayer DP, Kouttab N, Hearing VJ, Wanebo HJ. Immunization of mice with melanoma cells transfected to secrete the superantigen, staphylococcal enterotoxin A. Cancer Immunol Immunother. 1998 Mar; 46(1):7-13. PMID: 9520286.
    View in: PubMed
  8. Shrayer D, Park C, Kouttab N, Bogaars H, McInnis R, Paul S, Maizel A, Hearing V, Wanebo H. Intrasplenic vaccination against experimental melanoma. Int J Oncol. 1996 Jul; 9(1):123-9. PMID: 21541491.
    View in: PubMed
  9. Shrayer DP, Bogaars H, Hearing VJ, Wanebo HJ. Immunization of mice with irradiated melanoma tumor cells transfected to secrete lymphokines and coupled with IL-2 or GM-CSF therapy. J Exp Ther Oncol. 1996 Mar; 1(2):126-33. PMID: 9414396.
    View in: PubMed
  10. Shrayer D, Bogaars H, Hearing VJ, Maizel A, Wanebo H. Further characterization of a clinically relevant model of melanoma metastasis and an effective vaccine. Cancer Immunol Immunother. 1995 May; 40(5):277-82. PMID: 7600558.
    View in: PubMed
  11. Shrayer D, Bogaars H, Gersten D, Hearing V, Maizel A, Wanebo H. Nude mouse model to study passive humoral immunotherapy directed against B16 F10 murine melanoma. J Surg Oncol. 1994 Sep; 57(1):50-6. PMID: 8065154.
    View in: PubMed
  12. Shrayer D, Koness J, Kouttab N, Bogaars H, Hearing V, Maizel A, Wanebo H. Antitumor effects of polyvalent and monovalent vaccines coupled with interleukin-2 in a metastatic melanoma model. Int J Oncol. 1994 May; 4(5):1121-7. PMID: 21567029.
    View in: PubMed
  13. Shrayer D, Koness J, Kouttab N, Bogaars H, Hearing VJ, Gersten DM, Maizel A, Wanebo H. Preimmunization of mice with formalinized extracellular antigens of melanoma in combination with IL-2 and surgical resection increased survival and tumor control in metastatic melanoma model. J Surg Oncol. 1993 Mar; 52(3):142-9. PMID: 8441268.
    View in: PubMed
  14. Shrayer D, Kouttab N, Maizel A, Wanebo H, Hearing VJ, Gersten DM. Generation of cytotoxic antibodies to the B16 murine melanoma using a formalinized vaccine. Int J Cancer. 1993 Feb 20; 53(4):696-702. PMID: 8436442.
    View in: PubMed
  15. Shrayer D, Gersten DM, Koness J, Maizel A, Wanebo H, Hearing VJ. B700 antigen as a component of an antimelanoma vaccine: formalinized extracellular antigens. Pigment Cell Res. 1992 Sep; 5(3):107-12. PMID: 1409447.
    View in: PubMed
  16. Shrayer D, Koness J, Maizel A, Wanebo H. Induction of interleukin-2, natural killer cell activity and anti-melanoma antibodies resulting from immunization of mice with formalinized extracellular antigens (FECA) of murine melanoma. Melanoma Res. 1992 May; 2(1):47-56. PMID: 1643424.
    View in: PubMed
David's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
BU Co-Authors
_
Similar BU People
_
Same Department